Boston Private Wealth LLC lowered its stake in UnitedHealth Group Inc (NYSE:UNH) by 0.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 46,410 shares of the healthcare conglomerate’s stock after selling 423 shares during the quarter. Boston Private Wealth LLC’s holdings in UnitedHealth Group were worth $12,347,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. White Lighthouse Investment Management Inc. bought a new stake in UnitedHealth Group during the 2nd quarter valued at $324,000. Wells Fargo & Company MN increased its stake in UnitedHealth Group by 0.5% during the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after purchasing an additional 39,480 shares in the last quarter. Sawtooth Solutions LLC increased its stake in UnitedHealth Group by 34.4% during the 3rd quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock valued at $1,174,000 after purchasing an additional 1,129 shares in the last quarter. AXA increased its stake in UnitedHealth Group by 5.7% during the 3rd quarter. AXA now owns 911,581 shares of the healthcare conglomerate’s stock valued at $242,517,000 after purchasing an additional 49,227 shares in the last quarter. Finally, HL Financial Services LLC grew its stake in shares of UnitedHealth Group by 15.3% in the 3rd quarter. HL Financial Services LLC now owns 17,183 shares of the healthcare conglomerate’s stock worth $4,572,000 after acquiring an additional 2,281 shares in the last quarter. Institutional investors own 85.57% of the company’s stock.

Shares of NYSE:UNH opened at $278.55 on Thursday. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $270.68 billion, a P/E ratio of 27.66, a P/E/G ratio of 1.65 and a beta of 0.76. UnitedHealth Group Inc has a fifty-two week low of $208.48 and a fifty-two week high of $287.94.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The company had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm’s quarterly revenue was up 12.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.66 EPS. On average, analysts expect that UnitedHealth Group Inc will post 12.82 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.75%.

Several analysts have recently issued reports on UNH shares. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Raymond James upped their target price on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research note on Monday, September 24th. Oppenheimer upped their target price on shares of UnitedHealth Group from $295.00 to $300.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 28th. Bank of America upped their target price on shares of UnitedHealth Group from $315.00 to $320.00 and gave the stock a “buy” rating in a research note on Wednesday, October 17th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $292.00 target price for the company in a research note on Monday, November 26th. Two research analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $292.48.

In related news, CEO Steven H. Nelson sold 26,033 shares of the business’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $270.65, for a total value of $7,045,831.45. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 20,000 shares of the business’s stock in a transaction dated Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total transaction of $5,268,200.00. Following the completion of the transaction, the director now directly owns 1,720,112 shares in the company, valued at $453,094,701.92. The disclosure for this sale can be found here. Insiders sold a total of 60,428 shares of company stock worth $16,232,134 over the last three months. 0.87% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/unitedhealth-group-inc-unh-shares-sold-by-boston-private-wealth-llc/2664006.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: Discover Your Risk Tolerance

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.